The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
117345112 11734511 2 F 20100406 20160822 20151113 20160830 EXP FR-009507513-1010USA01114B1 MERCK 1.00 DY F Y 1.69000 KG 20160830 CN US FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
117345112 11734511 1 SS SUSTIVA EFAVIRENZ 1 Transplacental COURSE 1 Y U 0 CAPSULE
117345112 11734511 2 PS CELESTENE BETAMETHASONE 1 Transplacental DURING THE 2ND AND THE 3RD TRIMESTER OF PREGNANCY U U 14215 DISPERSIBLE TABLET
117345112 11734511 3 SS REYATAZ ATAZANAVIR SULFATE 1 Transplacental UNK U U 0
117345112 11734511 4 SS ZIAGEN ABACAVIR SULFATE 1 Transplacental COURSE 1 Y U 0
117345112 11734511 5 SS ZIAGEN ABACAVIR SULFATE 1 Transplacental COURSE 2 Y U 0
117345112 11734511 6 SS NORVIR RITONAVIR 1 Transplacental UNK U U 0
117345112 11734511 7 SS VIREAD TENOFOVIR DISOPROXIL FUMARATE 1 Transplacental COURSE 1 Y U 0
117345112 11734511 8 SS VIREAD TENOFOVIR DISOPROXIL FUMARATE 1 COURSE 2 Y U 0
117345112 11734511 9 SS RETROVIR ZIDOVUDINE 1 Transplacental U U 0
117345112 11734511 10 SS MICARDIS PLUS HYDROCHLOROTHIAZIDETELMISARTAN 1 Transplacental DURING THE 2ND AND 3RD TRIMESTER OF PREGNANCY U U 0
117345112 11734511 11 SS SPASFON PHLOROGLUCINOL 1 Transplacental DURING THE 2ND AND 3RD TRIMESTER OF PREGNANCY U U 0
117345112 11734511 12 SS CLAMOXYL AMOXICILLINCLAVULANIC ACID 1 Transplacental DURING THE 2ND AND 3RD TRIMESTER OF PREGNANCY U U 0
117345112 11734511 13 SS LOXEN NICARDIPINE HYDROCHLORIDE 1 Transplacental DURING THE 2ND AND 3RD TRIMESTER OF PREGNANCY U U 0
117345112 11734511 14 SS VITAMIN D CHOLECALCIFEROL 1 Transplacental DURING THE 3RD TRIMESTER OF PREGNANCY U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
117345112 11734511 1 Product used for unknown indication
117345112 11734511 3 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
117345112 11734511 CA
117345112 11734511 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
117345112 11734511 Cardiomegaly
117345112 11734511 Congenital pulmonary valve atresia
117345112 11734511 Congenital tricuspid valve atresia
117345112 11734511 Foetal exposure during pregnancy
117345112 11734511 Neonatal respiratory distress syndrome
117345112 11734511 Premature baby
117345112 11734511 Ventricular hypoplasia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
117345112 11734511 1 20091001 0
117345112 11734511 3 20091119 20100406 0
117345112 11734511 4 20091001 0
117345112 11734511 5 20091119 20100406 0
117345112 11734511 6 20091119 20100406 0
117345112 11734511 7 20091001 0
117345112 11734511 8 20091119 20100406 0
117345112 11734511 9 20100406 20100406 0
117345112 11734511 14 201002 0